Could Proteomic Research Deliver the Next Generation of Treatments for Pneumococcal Meningitis?
Table 1
The cell wall of S. pneumoniae has a diverse protein population, and pathogenic expression of pneumoccal proteins are associated with adherence to and colonisation of mucosal surfaces, resistance to specific and nonspecific host defences, penetration and invasion of host tissues, and generation of tissue damage mediated either directly by toxins or indirectly via inflammatory responses.
Protein
Description
Action
References
LytA
Enzyme required during cell division
Hydrolyses amide bonds between muramic acid and L-Alanine residues
Ranges from 67–99 kDa in size. Anchored to the outer layer of the plasma membrane
Reduces complement mediated clearance and phagocytosis of S. pneumoniae. Inhibits complement activation, thereby limiting opsonisation of pathogens by complement protein 3 (C3)
Cleaves terminal sialic acid residues from a wide variety of glycolipids, glycoproteins, and oligosaccharides
The precise role of NanA in pneumococcal disease is unknown. The relative contribution of NanB to disease has not been reported in either a sepsis or pneumonia model
Covalently linked to the cross-bridges of the cell wall peptidoglycan
Degrades essential components of the host's extracellular matrix (ECM), hyaluronan (HA), unsulfated chondroitin (CH), and certain chondroitin sulfates (CHSs)